DAY BY DAY Maintains Swiss Re AG

DAY BY DAY maintained a Buy on Swiss Re AG (OTCPK:SSREY) on Dec. 9, 2025, with the average one‑year analyst price target at $47.14 as of Nov. 17, 2025 — implying 48.99% upside from the latest close of $31.64 and a range of $18.86–$80.44. Analysts project annual revenue of $50,146MM (up 15.59%) and non‑GAAP EPS of 12.20, signaling robust earnings expectations. Institutional ownership is limited and slightly eroding — 12 funds hold the stock (unchanged quarter‑over‑quarter) with total reported shares down 4.22% to 98K and several managers trimming positions — which may temper immediate buying pressure despite sizeable analyst upside.

Analysis

DAY BY DAY maintained a Buy on Swiss Re AG – Depositary Receipt (OTCPK:SSREY) on December 9, 2025; the analyst consensus one‑year price target as of November 17, 2025 is $47.14, implying 48.99% upside from the latest close of $31.64 and a target range of $18.86–$80.44. This recommendation and target dispersion signal meaningful analyst conviction but also substantial disagreement on fair value.

Analysts project annual revenue of $50,146MM, a 15.59% increase, and a projected non‑GAAP EPS of 12.20, indicating consensus expectations for material top‑line and earnings growth embedded in the price targets. Those forward figures drive the upside case but are projections rather than reported results.

Institutional positioning is limited and softening: 12 funds report positions (unchanged quarter‑over‑quarter) while total institutional shares fell 4.22% to 98K. Notable managers trimmed holdings (Rhumbline, APIE, Yousif) even as average portfolio weight is a nominal 0.03% (reported up 0.48%), and sentiment measures show a moderately positive but low market‑impact profile.

The combination of sizable analyst upside, wide target range and declining institutional ownership suggests upside is primarily analyst‑driven with limited immediate buying support; near‑term performance will hinge on actual revenue/EPS delivery and whether institutions resume accumulation.

Key Decisions for Investors

• Consider a cautious, staged entry rather than a full position given the analyst‑implied 48.99% upside is offset by limited institutional ownership (98K shares) and wide $18.86–$80.44 target range
• Monitor upcoming results versus the projected $50,146MM revenue and non‑GAAP EPS of 12.20 and use those reports as primary triggers to increase or reduce exposure
• Watch 13F and fund filings for continued outflows from key holders (APIE, Rhumbline, Yousif) as confirmation of weak institutional demand before adding significant size
• If exposure is desired, size positions modestly (reflecting the 0.03% average portfolio weight) and consider protective hedges or staged buys to manage the execution risk created by divergent analyst targets